Description: This publication presents a graph on the trends in the use of GLP-1 receptor agonists (GLP-1RAs) among individuals with type 2 diabetes, obesity, or both, using nationwide electronic health record data from 2010 to 2023. It analyzes patterns of uptake across different demographic groups, highlighting disparities in access and adoption since FDA approval.

Citation: Li, P, Varghese, J.S., Shah, M.K., Pasquel, F.J., Harding, J.L., Hiao, T., Shao, H., Ali, M.K., 850-P: Trends in GLP-1RA Use among Individuals with Type 2 Diabetes (T2D) and/or Obesity—Insights from a Nationwide Electronic Health Record System, 2010–2023. Diabetes 14 June 2024; 73 (Supplement_1): 850–P. https://doi.org/10.2337/db24-850-P